Medicine and Dentistry
Computer Assisted Tomography
100%
Skeletal Muscle
86%
Sarcopenia
47%
Postoperative Complication
35%
Adipose Tissue
31%
Magnetic Resonance Imaging
28%
Skeletal Muscle Atrophy
26%
Arteriosclerosis Obliterans
26%
Ovarian Cancer
26%
Nerve Regeneration
26%
Kidney Function
26%
Psoas Muscle
24%
Chronic Obstructive Pulmonary Disease
24%
Abdominal Fat
24%
Odds Ratio
23%
Overall Survival
23%
Body Mass Index
22%
Cancer Surgery
21%
Muscle Atrophy
19%
Kidney Transplantation
19%
Skeletal Muscle
19%
Liver Transplantation
18%
Sarcopenic Obesity
17%
Meta-Analysis
17%
Injury
16%
Physical Activity
14%
Subarachnoid Hemorrhage
13%
Quality of Life
13%
Parastomal Hernia
13%
Colostomy
13%
Biological Marker
13%
Diagnosis
13%
Neoadjuvant Chemotherapy
13%
Protein Intake
13%
Biliary Atresia
13%
Colorectal Liver Metastasis
13%
Muscle Invasive Bladder Cancer
13%
Anthropometry
13%
Pelvis
13%
Dietary Intake
13%
Pediatrics
13%
Anterior Cruciate Ligament Reconstruction
13%
Tau
13%
Cystectomy
13%
Cadaver
13%
Skeletal Muscle Radiodensity
13%
Elderly Patient
13%
Revascularization
13%
Osteomyelitis
13%
Hepatectomy
13%
Keyphrases
Body Composition
44%
Myosteatosis
39%
Living Kidney Donor
39%
Computed Tomography
37%
Nerve Regeneration
26%
Kidney Function
26%
Skeletal muscle Index
24%
Abdominal Fat Area
24%
Muscle Quality
21%
Signal Intensity
20%
Functional Recovery
19%
Risk Factors
16%
Functional Outcome
15%
Muscle Mass
15%
Muscle Loss
14%
Low muscle Mass
14%
Muscle Measurement
14%
Pretransplant
14%
Body Mass Index
14%
Short tau Inversion Recovery
13%
Muscle Atrophy
13%
Magnetic Resonance Imaging
13%
Skeletal muscle Density
13%
Transurethral Resection of Bladder Tumor (TURBT)
13%
Lower Extremity
13%
Radiographic Predictors
13%
Quality Loss
13%
Muscle Quantity
13%
Body Metrics
13%
Revascularization
13%
Peripheral Arterial Disease
13%
Skeletal muscle Atrophy
13%
Imaging Biomarkers
13%
Neoadjuvant Chemoradiotherapy (nCRT)
13%
Machine Learning Classification
13%
Skeletal muscle Radiodensity
13%
DIEP Flap Breast Reconstruction
13%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
13%
Esophageal Cancer
13%
Physical Activity
13%
Physical Outcomes
13%
Grip Strength
13%
3D Printed Guide
13%
Protein Intake
13%
Non-response
13%
Outcome Association
13%
Cancer Patients
13%
PET Radiomics
13%
Prognostic Factors
13%
Kidney Transplantation
13%